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Article
Use of psychotropic medications by caregivers 
of elderly patients with dementia: is this a 
sign of caregiver burden?
Uso de psicotrópicos por cuidadores de pacientes idosos com demência: isso é um sinal 
de sobrecarga do cuidador?
Einstein Francisco Camargos1, Andrea Brígida Souza2, Aline Silva Nascimento2, Alessandra Cicari Morais-
e-Silva2, Juliana Lima Quintas3, Luciana Lilian Louzada1, Patricia Medeiros-Souza4
In Brazil, the elderly population approached 21 million in 
2009, and its growth is systematic and steady1.
The increase in the elderly population has occurred as 
a result of social progress, as well as advances in Medicine, 
which have reduced mortality during the early phases of life1. 
Although progress has been substantial for the treatment of 
some diseases, it lags behind in the case of neurodegenerative 
diseases, such as dementias2. 
Dementia is a chronic disease that is characterized by an 
irreversible impairment of the cognitive function. The preva-
lence of dementia worldwide is approximately 24 million with 
an estimated increase of 4.6 million new cases each year3. The 
current number of people with dementia in Latin America is 
1.8 million, and this is predicted to rise to 9.1 million by 20403.
In dementia, the loss of functionality initially causes depen-
dence with respect to the instrumental activities of daily living, 
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AbstrAct
This study evaluated the consumption of psychotropic medications by caregivers of elderly patients with or without dementia. This was a 
cross-sectional study conducted at all geriatric units in Brasília, Brazil, during a two-month period. Structured interviews were performed 
with 311 caregivers of people with or without dementia and they completed questionnaires. Among the caregivers, 196 (63%) were caregivers 
of patients with dementia and 115 (37%) were caregivers of patients without dementia. Forty-four caregivers (14.1%) were taking psycho-
tropic drugs (benzodiazepines or antidepressants), and this usage was more frequent among caregivers of patients with dementia (p<0.01). 
Twenty-two caregivers of patients with dementia (11.4%) had used sleeping pills after beginning care, compared with only five (4.3%) caregiv-
ers of patients without dementia (p<0.01). In conclusion, this study found that caregivers of patients with dementia took psychotropic drugs 
(benzodiazepines and antidepressants) more frequently than the ones of patients without dementia.
Key words: psychotropic drugs, aged, caregiver, dementia.
resUmo
Este estudo avaliou o consumo de drogas psicotrópicas por cuidadores de idosos de pacientes com e sem demência. Este foi um estudo trans-
versal conduzido em todas as unidades de atendimento geriátrico em Brasília, Brasil, durante dois meses. Foram realizadas entrevistas estru-
turadas e um questionário preenchido por 311 cuidadores de idosos, com e sem demência. Entre os cuidadores, 196 (63%) eram cuidadores 
de pacientes com demência e 115 (37%) de pacientes sem demência. Quarenta e quatro cuidadores (14,1%) estavam utilizando drogas psico-
trópicas (benzodiazepínicos ou antidepressivos). Esse uso foi mais frequente entre os cuidadores de pacientes com demência (p<0,01). Vinte e 
dois cuidadores de pacientes com demência (11,4%) usaram medicamentos para dormir após iniciar o trabalho de cuidador, comparado com 
somente 5 (4,3%) cuidadores de pacientes sem demência (p<0,01). Em conclusão, este estudo encontrou que cuidadores de pacientes com de-
mência tomavam mais frequentemente drogas psicotrópicas (benzodiazepínicos ou antidepressivos) do que os de pacientes sem demência.
Palavras-Chave: drogas psicotrópicas, idoso, cuidador, demência.
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and this is soon followed by dependence in terms of daily living 
basic activities, such as feeding, hygiene care, mobility, and so 
on. The caregiver of an elderly patient, either in a formal situa-
tion or a family member, usually assumes active participation 
with respect to care during the advanced phase of the disease.
A caregiver is defined as a person in the community or a 
family member that takes care of another people of any age, 
who need assistance, because they are bedridden, or have 
physical or mental limitations, with or without remunera-
tion4. The main informal caregiver is defined as the person 
entrusted to assist in the basic and instrumental activities of 
the patient’s daily life during the greater part of the day, with-
out receiving any remuneration5.
By that same concept, the task of the caregiver transcends 
simple assistance with daily activities of the individual, whether 
they are healthy, sick and/or bedridden, at risk or frail, in their 
home or in any type of institution in which they need daily care4. 
Caregivers of patients with dementia have unique challenges, for 
example difficulties with communication and the behavioural 
disorders that are observed in these patients, such as insomnia, 
night wandering, agitation, delusions, and others6.
The caregiver is usually a member of the family, that is, the 
wife or the patient’s son/daughter, and is frequently female. 
There is a large number of publications that describe the burden 
of caregivers of patients with dementia6. They have a poor qual-
ity of life, and show symptoms of anxiety, depression, insomnia, 
and stress7,8. As a consequence, the caregivers of elderly people 
with dementia are more susceptible to the use of psychotropic 
medications than other groups of people of the same age.
Few international studies have addressed this issue. Clipp 
and George9 evaluated 510 caregivers of patients with demen-
tia. The authors observed that one-third of them occasionally 
used a psychotropic drug, and 19% used anxiolytic, 4% antide-
pressant, and 18% hypnotic/sedative agents. They used scales 
for physical and mental evaluation to relate the complaints 
of the caregivers to the use of psychotropic medication, and 
found that a lack of social support during care was associated 
with a 3.7-fold increase in the use of antidepressants.
Given the ageing of the Brazilian population, the resulting 
increase in the number of individuals with dementia, and the 
consequent increase in the number of caregivers of people with 
dementia, aspects related to the health of caregivers should be 
considered as part of public health policy. The objective of this 
study was to investigate the use of psychotropic medications 
by caregivers of elderly patients with (CPD) or without (CPND) 
dementia in clinics of geriatric medicine in Brasília, Brazil.
metHoDs
Design and setting
This was a cross-sectional study conducted on CPD and 
CPND from four centres of geriatric medicine in the Federal 
District of Brazil (DF) from July to August, 2010. The centres 
were: Center of Medicine of the Elderly (CMI) of the University 
Hospital of Brasília, University of Brasília; Geriatrics Clinic of 
the Regional Hospital of the North Wing (HRAN); Geriatrics 
Clinic of the Regional Hospital of Guará (HRGu); and the 
General Clinic of Taguatinga (HRT). These services are re-
sponsible for all public services related to elderly people in 
DF and they are part of the Brazilian Public Health System 
(SUS). The CMI is accredited by the Brazilian Ministry of 
Health as a referral centre for patients with Alzheimer’s dis-
ease in the Brazilian Federal District. 
This research was approved by the Ethics Research 
Committee of the Medical University of Brasília (n. 007/10) 
and by the Secretary of State for Health (n. 210/10).
Participants
Definition of caregiver according to the Brazilian Ministry 
of Health: “family member or person from the community 
who takes care of another person of any age who needs assis-
tance because they are bedridden, or have physical or mental 
limitations, with or without remuneration”.
Psychotropic medications act upon the central nervous 
system (CNS) to produce alterations in behaviour, humour, 
and cognition; they possess substantial reinforcing proper-
ties, and thus are susceptible to self-administration10.
The established guidelines for the diagnosis of dementia 
used by the clinics followed the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV) by the American 
Association of Psychiatry11.
In this study, only the use of benzodiazepines and antide-
pressants was analysed. The study did not consider the use of 
antipsychotic, anticonvulsant, or other drugs that act upon 
the CNS.
interview
The caregivers that followed-up an elderly patient in the 
geriatric consultations, which took place between July, 1 and 
August, 30, in 2010, were invited to participate in an inter-
view. After the caregivers had signed the informed consent 
form, they were interviewed by the research pharmacist, and 
data related to the patient were acquired from medical files. 
Ten caregivers refused consent. The questions posed to the 
caregivers were in accordance with the following sequence:
•	 Have	you	ever	used	tranquilizers,	sedatives	or	antidepressants	
since you began to care for this elderly patient? Yes or no.
•	 Are	you	taking	such	drugs	currently?	Yes	or	no.
•	 No,	you	are	not	using	such	drugs	currently,	but	have	you	
used them before? Yes or no.
The names of any medications used were supplied by the 
user and classified by the pharmacist as antidepressant, ben-
zodiazepine, and antianxiety.
Health and sociodemographic characteristics were com-
pared between the two groups (response variable): namely, 
CPND (=0) or CPD (=1).
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Patient variables
These variables included the location of the medical ap-
pointment, age, gender ( female=1); insomnia (present=1), 
night wandering (present=1), night agitation (present=1), 
and the use of sleep medication (yes=1).
Caregiver variables 
These included: age; gender ( female=1); education, con-
sidered in terms of complete years of study and expressed as 
a dichotomous variable: >8 years=0 and <8 years=1; marital 
status (married, single, separate/divorced, other); other work 
activity (yes=1); member of the family (yes=1); nature of the 
family relationship (spouse, son/daughter, other); schedule 
of caregiving continual, a 12-hour period per day, alternate 
days, weekends, others); use of any medication (yes=1); use of 
any prescription-controlled medication (yes=1); use of ben-
zodiazepines (yes=1); use of antidepressants (yes=1); use of 
sleeping pills while taking care of the elderly patient (yes=1); 
and self-notification of the caregiver’s health condition (ex-
cellent, very good, good, bad, and very bad).
statistical analysis
The statistical analysis was begun by using the 
Kolmogorov-Smirnov test for normality. Pearson’s χ2, the 
Kruskal-Wallis, and Student’s t tests were used to verify the 
statistical significance of the differences found among pro-
portions and averages. The analyses were performed using 
the statistical program SPSS, version 17.0. All of the p-values 
were two-tailed (α=0.05). 
resUlts
A total of 311 caregivers of elderly patients were inter-
viewed: 196 (63%) in the CPD Group and 115 (37%) in the 
CPND Group. The mean age of the elderly patients was 77.7 
years (±8.3), and there was no difference between the groups 
with respect to gender. The sociodemographic characteris-
tics and the health status of the patients are given in Table 1.
The mean age among the caregivers overall was 50.7 years-old 
(±14.0). The CPD Group had a greater mean age than the CNPD 
Group (51.9±13.6 versus 48.7±14.4 years-old, p=0.04). The so-
ciodemographic characteristics of the caregivers and their re-
lationship to the use of medications by the CPD and CNPD 









Place of medical care
CMI 100 (51.0) 43 (37.4) -
HRAN 35 (17.9) 41 (35.7) <0.001
HRT Clinic 46 (23.5) 19 (16.5) 0.8
HRGu 15 (7.7) 12 (10.4) 0.1
Gender
Male 63 (32.1) 32 (27.8) 0.2
Female 133 (67.9) 83 (72.2)
Insomnia
Yes 93 (47.4) 39 (33.9) 0.02
No 103 (52.6) 76 (66.1)
Night wandering
Yes 41 (20.9) 12 (10.4) 0.01
No 155 (79.1) 103 (89.6)
Night agitation
Yes 67 (34.2) 21 (18.3) 0.003
No 129 (65.8) 94 (81.7)
Does he/she use sleep 
medication?
Yes 117 (59.7) 40 (34.8) <0.001
No 79 (40.3) 75 (65.2)
Table 1. Physical and sociodemographic characteristics of the 
patients (n=311).
*Pearson’s correlation; CMI: Center of Medicine of the Elderly; HRAN: Regional 











Male 33 (16.8) 28 (24.3) 0.1
Female 163 (83.2) 87 (75.7)
Educational level
≤8 years 77 (39.3) 37 (32.2) 0.2
>8 years 119 (60.7) 78 (67.8)
Marital status
Married 117 (59.7) 67 (58.3) 0.8#
Single 50 (25.5) 30 (26.1)
Separated/divorced 21 (10.7) 11 (9.6)
Other 8 (4.1) 7 (6.1)
Does he/she have another work 
activity?
Yes 72 (36.7) 55 (47.8) 0.054
No 124 (63.3) 60 (52.2)
Is he/she a member of the family?
Yes 176 (89.8) 110 (95.7) 0.06
No 20 (10.2) 05 (4.3)
Family relationship
Husband/wife 38 (21.6) 19 (17.3) 0.7#
Son/daughter 126 (71.6) 69 (62.7)
Other 32 (16.3) 27 (23.5)
Working shift
Continual 133 (67.9) 70 (60.9) 0.4#
12-hour period 22 (11.2) 10 (8.7)
Alternate days 11 (5.6) 11 (9.6)
Weekends 10 (5.1) 09 (7.8)
Other 20 (10.2) 15 (13.0)
Table 2. Physical and sociodemographic characteristics of 
caregivers of elderly patients with or without dementia (n=311).
*Pearson’s correlation; #Kruskal-Wallis test.
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Forty-four caregivers (14.1%) used psychotropic medica-
tions, and this use was more frequent among the CPD Group 
than among the CPND one (n=36 versus n=8, p<0.01). Among 
these 44 caregivers, 15 (4.8%) used benzodiazepines and 27 
(8.6%), antidepressants.
DiscUssioN
This study, which took place in centres of geriatric medicine 
in Brasília, found that the CPD Group used medications, mainly 
psychotropic drugs, more frequently than the CNPD one.
The patient’s sample was representative of the routine 
medical service in geriatric clinics, and it included patients 
both with and without dementia. The large proportion of pa-
tients with dementia among the group from the CMI was due 
to the fact this centre is a referral centre for the treatment of 
such disease in the DF. With regard to the individual charac-
teristics recorded during the study, the presence of sleep dis-
turbance, night wandering and night agitation, and the use 
of sleeping pills were common in the patients with demen-
tia12. Although the diagnosis of sleep disturbance in patients 
with this condition is based on specific criteria, the informa-
tion provided by the caregiver should be considered to be 
basically subjective, in spite of being similar in the two groups 
of caregivers (CPD and CNPD).
The characteristics of the patient show a direct relation-
ship with the quality of life of the caregiver. Caregivers of de-
mentia patients with sleep disturbance complain more fre-
quently of insomnia than the ones of patients with dementia, 
whose sleep is not disturbed. In fact, this is an important cause 
of institutionalization in nursing homes13. Night wandering 
and agitation has an equal impact on the quality of life of the 
caregiver and patient. Moreover, research has shown that care-
givers of patients with dementia have high levels of hormones 
related to stress and a low antibody response to infection14.
Regarding the sample of caregivers, the gender distribu-
tion did not differ from that observed in other Brazilian and 
international studies; the sample being composed basically 
of women9,15,16. In this study, the majority of caregivers was 
the unemployed sons/daughters of patients who did not 
have a job but had a high level of education. The involvement 
of sons/daughters as caregivers and their advanced age (a 
mean of 48 years-old) have also been observed in other na-
tional and international studies7,15,17.
Caregivers of elderly patients with dementia have a poor 
quality of life and are more likely to have insomnia and de-
pression, as well as more severe health conditions7,8,18. Their 
symptoms depend on the severity of the patient’s dementia7. 
It was not an objective of the present study to evaluate the 
presence of insomnia or depression in caregivers.
It was observed that 44 (14%) of the caregivers used psy-
chotropic medications, the majority being antidepressants. 
This proportion is higher than the frequency of use of psy-
chotropic medications in the general population, as reported 
in previous studies. For example, Rodrigues et al. found that, 
in the city of Pelotas, psychotropic medications were used by 
9.9% of the population19.
With regard to the use of psychotropic drugs by caregiv-
ers, other studies observed high levels of use, which varied 
from 24 to 31%9,20-22. Study by Clipp and George9, which in-
volved 510 American caregivers of patients with dementia, 
demonstrated that 30% used psychotropic medications oc-
casionally. Subsequent studies have identified a high preva-
lence (31%) of the use of psychotropic drugs by caregivers of 
stroke victims20. Similarly to the current study, these stud-
ies used questionnaires to obtain the required information. 
Factors that predispose caregivers to the use of psychotro-
pic medication are: female sex, low educational level, fre-
quent medical appointments, high number of stress factors, 
low life satisfaction, poor health status9,18 and a large num-
ber of diseases18. 
A study based on a questionnaire survey of 2,032 American 
caregivers of patients with dementia found that Caucasians 
used approximately twice as many antidepressants and anxi-
olytic agents as African-Americans18. The same study did not 
identify a relationship between the use of psychotropic medi-
cations and the severity of the dementia, but it identified an 
Table 3. Use of medications, psychotropic medications, and 
health condition of caregivers of elderly patients with or 









Does he/she take any 
medication?
Yes 118 (60.2) 56 (48.7) 0.04
No 78 (39.8) 59 (51.3)
Does he/she use any 
prescription-controlled 
medication?
Yes 36 (18.4) 08 (7.0) 0.005
No 160 (81.6) 107 (93.0)
Does he/she take 
benzodiazepines?
Yes 14 (7.3) 01 (0.9) 0.01
No 179 (92.7) 114 (99.1)
Does he/she take 
antidepressants?
Yes 22 (11.4) 05 (4.3) 0.03
No 171 (88.6) 110 (95.7)
Did he/she use sleep 
medication while taking care 
of the elderly patient?
Yes 62 (31.6) 18 (15.7) 0.002
No 134 (68.4) 97 (84.3)
How does he/she consider 
his/her health condition?
Good, very good or excellent 174 (88.8) 105 (91.3) 0.4
Bad or very bad 22 (11.2) 10 (8.8)
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inverse relationship between age and the use of antidepres-
sants, which occurred more frequently among young care-
givers. The authors suggested that younger caregivers might 
request more prescriptions for antidepressants from their 
doctors than older ones. Surprisingly, they noted that 23% 
of the caregivers with depression used anxiolytic agents, and 
only 19% were treated with antidepressants.
It is important to note that a decrease in social activities 
can be associated with the use of psychotropic drugs. The 
loss of friends, leisure activities or work, as well as the com-
plaint of lack of time for oneself, has been related to the use 
of psychotropic medication by caregivers9. More than half of 
the caregivers in this earlier study thought that they received 
little or insufficient help from relatives, with respect to the 
care of the patient. However, the author of the study point-
ed out that it was not clear whether the perception of inad-
equate support itself predicted the increased use of psycho-
tropic medication. 
An American study composed by a rural population, 
which involved caregivers of elderly patients with dementia, 
showed that the participants significantly used more psycho-
tropic medications without medical prescription (to treat in-
somnia) than those who were not caregivers (43 versus 3%)23. 
In the present study, members of the CPD Group used more 
sleeping pills during the time they took care of an elderly 
patient than members of the CPND Group. Information on 
which medication was used was difficult to obtain, owing 
to the fact that the caregivers often did not remember the 
names of the drugs. However, this reinforced the possible oc-
currence of insomnia among the CPD Group.
Physicians that assist patients with dementia must be 
aware of the caregiver’s health. Psychological interventions 
can reduce the psychological morbidity of caregivers24. Six or 
more sessions of psychological behavioural therapy for family 
caregivers of patients with dementia reduce the symptoms of 
psychological disease. Group therapy seems to be less effec-
tive than individual therapy16.
A Dutch study of 984 informal caregivers identified the de-
mands and needs for professional support of caregivers that 
take care of patients with dementia. There was a difference be-
tween the demands of wives and those of sons/daughters: wives 
needed more emotional support and sons/daughters need-
ed more information about care in the advanced stages of 
dementia25. This type of study needs to be repeated in Brazil. 
Knowledge of the needs of caregivers can improve their 
quality of life and that of the patient26, in addition to having 
a significant impact on public health.
The present study has some limitations, which include 
the fact that information about psychotropic medication was 
obtained from caregivers’ self-reports. Depressive or physical 
complaints were not analysed, although the self-perception 
of health was analysed. These results cannot be extended to 
all caregivers, and more studies are necessary, with appropri-
ate study designs, and in other areas of Brazil.
It is likely that the number of caregivers in Brazil will in-
crease in parallel with the rapid growth of the elderly popu-
lation. Government strategies to deal with the characteris-
tics and specific demands of this category of workers should 
be developed. Caregivers are a group that is susceptible to 
psychological disease and stress. Some authors use the term 
“Caregivers’ syndrome” to categorize the events that are com-
monly observed in this population27.
In summary, we observed that caregivers of patients with 
dementia took more psychotropic medications than the ones 
of patients without dementia. This finding might be an indi-
rect sign of caregiver burden. This research showed the need 
for proper health care and a reduction of psychotropic drug 
consumption by caregivers of patients with dementia.
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